Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
E Martínez, JA Arranz, D Podzamczer, M Lonca, J Sanz, P Barragán, H Knobel, E Ribera, F Gutierrez, S Valero, B Clotet, D Dalmau, F Segura, JR Arribas, P Barrufet, I Santos, A Payeras, E de Lazzari, JVolume:
13
Language:
english
Pages:
1
DOI:
10.1186/1758-2652-13-s4-p43
Date:
November, 2010
File:
PDF, 185 KB
english, 2010